Immunogenicity of Ad26.COV2.S vaccine against SARS-CoV-2 variants in humansGalit Alter(Ragon Institute of MGH, MIT and Harvard), Dan H. Barouch(Beth Israel Deaconess Medical Center)NatureJune 9, 202110.1038/s41586-021-03681-2Cited by 349SaveCiteExport RISWatch citationsRelated PapersDNA vaccine protection against SARS-CoV-2 in rhesus macaques|Science|2020|1.1kSingle-shot Ad26 vaccine protects against SARS-CoV-2 in rhesus macaques|Nature|2020|904Vaccine protection against acquisition of neutralization-resistant SIV challenges in rhesus monkeys|Nature|2012|466Vaccines elicit highly conserved cellular immunity to SARS-CoV-2 Omicron|Nature|2022|459Immune control of an SIV challenge by a T-cell-based vaccine in rhesus monkeys|Nature|2008|448